Detailed View
BVS - Bioventus Inc.
Latest filing: 2026-06-27 | Reporting: gaap
Market Cap
1,033,835,200
Adj EBIT (TTM)
73,202,000
Enterprise Value
1,311,124,200
Last Price
15.26
Earnings Yield
5.58%
Return on Capital
45.08%
Capital
162,387,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-27 | 10-Q | 2026 | 153,208,000 | 19,127,000 |
| 2026-03-28 | 10-Q | 2026 | 132,089,000 | 8,416,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 157,900,000 | 19,486,000 |
| 2025-09-27 | 10-Q | 2025 | 138,651,000 | 11,252,000 |
| 2025-06-28 | 10-Q | 2025 | 147,660,000 | 18,368,000 |
| 2025-03-29 | 10-Q | 2025 | 123,876,000 | 4,869,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 153,642,000 | 7,988,000 |
| 2024-09-28 | 10-Q | 2024 | 138,964,000 | 4,074,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.